Danish drug developer Novo Nordisk on Wednesday presented “strong” sales expectations for 2023 and announced heavy investments into its production capacity, but warned of supply constraints on its best-selling drug.
As the healthcare journey for patients living with cancer has changed, so has the way in which pharmaceutical companies bring a drug to market. Med Ad News spoke with Anne Marie Robertson, SVP, strategy & marketing, EVERSANA about how companies need to rethink traditional commercialization models in oncology to be agile in today’s market.
Dentsu today announced the appointment of Eduardo Tavares as Executive Creative Director, dentsu health. In this role, multi-award winner Tavares, will concept and deliver best-in-class creative campaigns – merging data and technology with craft – to drive value and competitive advantage for dentsu health clients across health & wellness and pharmaceutical sectors.
To effectively promote your brand, it is important to have a message that stands out and a story that will capture the attention of your target audience. We have utilized oncology message benchmarks to study more than 30,000 interactions between oncologists and sales representatives for over 100 brands to understand what makes them tick.
Although the pandemic gave a boost to the drug discovery market, accelerated development in the market will be influenced by effective use of data and analytics.
The FDA’s Peripheral and Central Nervous System Drugs advisory committee will discuss the merits of Biogen and Ionis’s ALS candidate tofersen on March 22nd.
In his role, Reilly will continue to drive the rapid growth and innovation of health marketing services across dentsu.
Yesterday, Astellas announced that the FDA had lifted its clinical hold for the company’s experimental gene therapy trial for late-onset Pompe disease. The therapy was placed on clinical hold in June 2022 after a study participant experienced a severe adverse event.
As our nation attempts to pick itself up and walk away from the COVID battlefield, we can see the toll it has suffered. COVID spurred a pervasive physical and mental health crisis in the United States, but it has also precipitated a financial and operational crisis among our most important healthcare institutions.
Renata Maia joins the agency from IPG Health’s award-winning AREA 23.
